Traditionally the un-weighted Z-tests, which follow the one-patient-one-vote principle, are standard for comparisons of treatment effects. We discuss two types of weighted Z-tests in this manuscript to incorporate data collected in two (or more) stages or in two (or more) regions. We use the type A weighted Z-test to exemplify the variance spending approach in the first part of this manuscript. This approach has been applied to sample size re-estimation. In the second part of the manuscript, we introduce the type B weighted Z-tests and apply them to the design of bridging studies. The weights in the type A weighted Z-tests are pre-determined, independent of the prior observed data, and controls alpha at the desired level. To the contrary, the weights in the type B weighted Z-tests may depend on the prior observed data; and the type I error rate for the bridging study is usually inflated to a level higher than that of a full-scale study. The choice of the weights provides a simple statistical framework for communication between the regulatory agency and the sponsor. The negotiation process may involve practical constrains and some characteristics of prior studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1081/BIP-200062284 | DOI Listing |
J Diabetes Investig
December 2024
Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Objective: This ACTION-IO sub-analysis compared attitudes of people with obesity (PwO) and healthcare professionals (HCPs) between South Korea/Japan and global.
Methods: Responses from overall (body mass index [BMI] ≥ 25 kg/m) and higher BMI (30.0-34.
ESC Heart Fail
December 2024
Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Aims: Renin-angiotensin-aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium cyclosilicate (SZC). This observational study describes the likelihood of continued RAASi therapy by duration of SZC treatment.
View Article and Find Full Text PDFFront Neurol
February 2024
Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, United States.
Background: Portable low-field-strength magnetic resonance imaging (MRI) systems represent a promising alternative to traditional high-field-strength systems with the potential to make MR technology available at scale in low-resource settings. However, lower image quality and resolution may limit the research and clinical potential of these devices. We tested two super-resolution methods to enhance image quality in a low-field MR system and compared their correspondence with images acquired from a high-field system in a sample of young people.
View Article and Find Full Text PDFJ Phys Act Health
December 2023
Coastal Carolina University, Conway, SC, USA.
Background: Physical inactivity prevalence estimates for youth and adults have been published on a global scale and for various geographical and geopolitical permutations. Only one such study has presented estimates for adults in Muslim countries, and it is nearly 10 years old. I conducted an update of this study by incorporating newer data, refining methods, and including youth estimates.
View Article and Find Full Text PDFTens of thousands of simultaneous hypothesis tests are routinely performed in genomic studies to identify differentially expressed genes. However, due to unmeasured confounders, many standard statistical approaches may be substantially biased. This paper investigates the large-scale hypothesis testing problem for multivariate generalized linear models in the presence of confounding effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!